149 related articles for article (PubMed ID: 1501272)
1. Nuclear factors that bind two regions important to transcriptional activity of the simian immunodeficiency virus long terminal repeat.
Winandy S; Renjifo B; Li Y; Hopkins N
J Virol; 1992 Sep; 66(9):5216-23. PubMed ID: 1501272
[TBL] [Abstract][Full Text] [Related]
2. cis-acting elements in the U3 region of a simian immunodeficiency virus.
Renjifo B; Speck NA; Winandy S; Hopkins N; Li Y
J Virol; 1990 Jun; 64(6):3130-4. PubMed ID: 2335831
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
Maciaszek JW; Talmage DA; Viglianti GA
J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
[TBL] [Abstract][Full Text] [Related]
4. Identification of a large bent DNA domain and binding sites for serum response factor adjacent to the NFI repeat cluster and enhancer region in the major IE94 promoter from simian cytomegalovirus.
Chang YN; Jeang KT; Chiou CJ; Chan YJ; Pizzorno M; Hayward GS
J Virol; 1993 Jan; 67(1):516-29. PubMed ID: 8380090
[TBL] [Abstract][Full Text] [Related]
5. Sequences just upstream of the simian immunodeficiency virus core enhancer allow efficient replication in the absence of NF-kappaB and Sp1 binding elements.
Pöhlmann S; Flöss S; Ilyinskii PO; Stamminger T; Kirchhoff F
J Virol; 1998 Jul; 72(7):5589-98. PubMed ID: 9621017
[TBL] [Abstract][Full Text] [Related]
6. Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements.
Markovitz DM; Smith MJ; Hilfinger J; Hannibal MC; Petryniak B; Nabel GJ
J Virol; 1992 Sep; 66(9):5479-84. PubMed ID: 1501284
[TBL] [Abstract][Full Text] [Related]
7. NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation.
Sambucetti LC; Cherrington JM; Wilkinson GW; Mocarski ES
EMBO J; 1989 Dec; 8(13):4251-8. PubMed ID: 2556267
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the transcriptional activity of the long terminal repeats of simian immunodeficiency viruses SIVmac251 and SIVmac239 in T-cell lines and macrophage cell lines.
Anderson MG; Clements JE
J Virol; 1991 Jan; 65(1):51-60. PubMed ID: 1985214
[TBL] [Abstract][Full Text] [Related]
9. Simian immunodeficiency viruses containing mutations in the long terminal repeat NF-kappa B or Sp1 binding sites replicate efficiently in T cells and PHA-stimulated PBMCs.
Zhang J; Novembre F; Rabson AB
Virus Res; 1997 Jun; 49(2):205-13. PubMed ID: 9213395
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
Sparger EE; Shacklett BL; Renshaw-Gegg L; Barry PA; Pedersen NC; Elder JH; Luciw PA
Virology; 1992 Mar; 187(1):165-77. PubMed ID: 1310554
[TBL] [Abstract][Full Text] [Related]
11. The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells.
Clark NM; Hannibal MC; Markovitz DM
J Virol; 1995 Aug; 69(8):4854-62. PubMed ID: 7609053
[TBL] [Abstract][Full Text] [Related]
12. Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant SIVsmmPBj14.
Dollard SC; Gummuluru S; Tsang S; Fultz PN; Dewhurst S
J Virol; 1994 Dec; 68(12):7800-9. PubMed ID: 7966569
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
Twu JS; Chu K; Robinson WS
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
[TBL] [Abstract][Full Text] [Related]
14. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
15. cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat.
Fong SE; Pallansch LA; Mikovits JA; Lackman-Smith CS; Ruscetti FW; Gonda MA
Virology; 1995 Jun; 209(2):604-14. PubMed ID: 7778292
[TBL] [Abstract][Full Text] [Related]
16. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
[TBL] [Abstract][Full Text] [Related]
17. Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.
Gaynor RB; Kuwabara MD; Wu FK; Garcia JA; Harrich D; Briskin M; Wall R; Sigman DS
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9406-10. PubMed ID: 3200827
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor AP-2 regulates human immunodeficiency virus type 1 gene expression.
Perkins ND; Agranoff AB; Duckett CS; Nabel GJ
J Virol; 1994 Oct; 68(10):6820-3. PubMed ID: 8084021
[TBL] [Abstract][Full Text] [Related]
19. Conserved high-affinity NF-kappa B binding site in the interferon regulatory factor-1 promoter is not occupied by NF-kappa B in vivo and is transcriptionally inactive.
Rein T; Schreck R; Willenbrink W; Neubert WJ; Zorbas H; Bäuerle PA
J Inflamm; 1995; 45(4):269-82. PubMed ID: 8867671
[TBL] [Abstract][Full Text] [Related]
20. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
Bowers WJ; Baglia LA; Ruddel A
J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
